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Comorbidity is defined as conditions which are associated with
the specific disorders and may occur in the general population
at the same time. The association of migraine with various psyc-
hological characteristics such as depression perfectionism and
autonomic reactivity has been described by clinicians for more
than a century. The data generated from numerous large, po-
pulation-based studies have demonstrated that impact of co-
morbidity on the onset, course and severity of migraine, as well
as use of services and response to treatment. The strong asso-
ciation of migraine with both depression and anxiety should be
considered in the treatment of individuals with migraine.
A case report illustrates the complex issue of psychiatric co-
morbidity. Overall, the young patient presents with migraine
without aura, exacerbated by the onset of possible medication
overuse headache during past six months. The disorder worse-
ned since she began to have depression, which was determined
to be of moderate severity. On account of the family history of
alcoholism and current medication overuse, there is a need of
assessment of dependence on acute antimigraine drugs and
other substances. The possible history of anxiety disorders, and
major depressive episodes, when considered together with her
family history of maternal puerperal major depression and al-
coholism in the paternal grandfather, raise concerns about
major depression and anxiety.
In a first step, ambulatory withdrawal was proposed to the pa-
tient after two consultations with a neurologist and psychia-
trist. These interviews were intended to access the current
medical condition, to make treatment objectives clear for the
patient and to initiate therapeutic education. During the with-
drawal period, the patient was asked to take no more than two
tablets per week of frovatriptan and we initiated a preventive
treatment with topiramate. Withdrawal headaches staggered
over the first five days and were bravely endured by the patient.
We also performed psychological support and relaxation ses-
sions once per week during the first two months, and we advi-
sed the patient to complement them with a stress management
therapy. Evolution was favorable, both concerning the migraine
as well as mood.
Individuals with migraine shoe increase odds of developing de-
pression or anxiety. The mechanisms of comorbidity likely
comprise both common risk factors and causal links. Potential
treatment for migraine accompanied by depression include an-
tidepressants and other mood regulators; they may lead to re-
mission of symptoms of migraine and co-occuring depression
and anxiety.
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